Scott Fidel
Stock Analyst at Stephens & Co.
(4.24)
# 467
Out of 4,711 analysts
176
Total ratings
66.67%
Success rate
8.96%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Scott Fidel
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CNC Centene | Maintains: Equal-Weight | $75 → $73 | $59.58 | +22.52% | 9 | Dec 13, 2024 | |
| UNH UnitedHealth Group | Maintains: Overweight | $605 → $675 | $500.13 | +34.96% | 22 | Dec 5, 2024 | |
| ALHC Alignment Healthcare | Upgrades: Overweight | $13 → $17 | $10.61 | +60.23% | 4 | Dec 3, 2024 | |
| PACS PACS Group | Maintains: Overweight | $48 → $31 | $13.01 | +138.28% | 4 | Nov 18, 2024 | |
| ADUS Addus HomeCare | Maintains: Overweight | $143 → $145 | $131.40 | +10.35% | 11 | Nov 6, 2024 | |
| CI The Cigna Group | Reiterates: Overweight | $410 | $276.92 | +48.06% | 12 | Nov 1, 2024 | |
| ENSG The Ensign Group | Maintains: Overweight | $163 → $167 | $134.59 | +24.08% | 9 | Oct 28, 2024 | |
| GRDN Guardian Pharmacy Services | Initiates: Overweight | $21 | $21.41 | -1.91% | 1 | Oct 22, 2024 | |
| HUM Humana | Reiterates: Equal-Weight | $250 | $247.10 | +1.17% | 7 | Oct 9, 2024 | |
| PNTG The Pennant Group | Reiterates: Overweight | $40 | $27.38 | +46.09% | 17 | Oct 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $24 | $16.01 | +49.91% | 2 | Sep 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $615 | $365.96 | +68.05% | 3 | Sep 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $105 | $94.45 | +11.17% | 10 | Aug 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Equal-Weight | $320 | $294.73 | +8.57% | 9 | Jul 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Equal-Weight | $200 | $180.11 | +11.04% | 9 | Jul 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $95 → $122 | $129.46 | -5.76% | 10 | May 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $92 | $37.90 | +142.74% | 9 | Jan 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $280 | $303.62 | -7.78% | 9 | Nov 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $95 | $11.13 | +753.55% | 4 | Jun 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Equal-Weight | $103 | $84.47 | +21.94% | 12 | May 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $2.25 → $1.5 | $4.58 | -67.25% | 3 | Nov 11, 2022 |
Centene
Dec 13, 2024
Maintains: Equal-Weight
Price Target: $75 → $73
Current: $59.58
Upside: +22.52%
UnitedHealth Group
Dec 5, 2024
Maintains: Overweight
Price Target: $605 → $675
Current: $500.13
Upside: +34.96%
Alignment Healthcare
Dec 3, 2024
Upgrades: Overweight
Price Target: $13 → $17
Current: $10.61
Upside: +60.23%
PACS Group
Nov 18, 2024
Maintains: Overweight
Price Target: $48 → $31
Current: $13.01
Upside: +138.28%
Addus HomeCare
Nov 6, 2024
Maintains: Overweight
Price Target: $143 → $145
Current: $131.40
Upside: +10.35%
The Cigna Group
Nov 1, 2024
Reiterates: Overweight
Price Target: $410
Current: $276.92
Upside: +48.06%
The Ensign Group
Oct 28, 2024
Maintains: Overweight
Price Target: $163 → $167
Current: $134.59
Upside: +24.08%
Guardian Pharmacy Services
Oct 22, 2024
Initiates: Overweight
Price Target: $21
Current: $21.41
Upside: -1.91%
Humana
Oct 9, 2024
Reiterates: Equal-Weight
Price Target: $250
Current: $247.10
Upside: +1.17%
The Pennant Group
Oct 9, 2024
Reiterates: Overweight
Price Target: $40
Current: $27.38
Upside: +46.09%
Sep 19, 2024
Reiterates: Overweight
Price Target: $24
Current: $16.01
Upside: +49.91%
Sep 5, 2024
Reiterates: Overweight
Price Target: $615
Current: $365.96
Upside: +68.05%
Aug 6, 2024
Reiterates: Overweight
Price Target: $105
Current: $94.45
Upside: +11.17%
Jul 25, 2024
Reiterates: Equal-Weight
Price Target: $320
Current: $294.73
Upside: +8.57%
Jul 25, 2024
Reiterates: Equal-Weight
Price Target: $200
Current: $180.11
Upside: +11.04%
May 1, 2024
Maintains: Equal-Weight
Price Target: $95 → $122
Current: $129.46
Upside: -5.76%
Jan 5, 2024
Upgrades: Overweight
Price Target: $92
Current: $37.90
Upside: +142.74%
Nov 10, 2023
Reiterates: Overweight
Price Target: $280
Current: $303.62
Upside: -7.78%
Jun 27, 2023
Reiterates: Overweight
Price Target: $95
Current: $11.13
Upside: +753.55%
May 4, 2023
Reiterates: Equal-Weight
Price Target: $103
Current: $84.47
Upside: +21.94%
Nov 11, 2022
Maintains: Equal-Weight
Price Target: $2.25 → $1.5
Current: $4.58
Upside: -67.25%